|
|
by Ted Driscoll on May 3rd, 2013 
Congratulations to Claremont Creek portfolio company Natera on closing a $54.6 million financing round. Given Claremont Creek Venture’s involvement since the company’s earliest round of financing, we know Natera is on its way to dominating the market for noninvasive, prenatal genetic testing. The financing is just the latest recent milestone for the company. In February it announced a major agreement with Quest Diagnostics, the world’s leading diagnostic information . . .
→ Read full post: Congratulations to Natera on Completing $54.6 Million Financing to Support Expansion
by Randy Hawks on April 19th, 2013 
Randy Hawks, Managing Director
Claremont Creek Ventures is proud of the recent success of our eCommerce/payment portfolio company, SmartZip. During the first quarter of 2013, SmartZip’s SmartTargeting solution for real estate professionals achieved a 300% revenue increase over the same quarter just one year ago. In this current real estate climate, these results are impressive to say the least.
SmartZip’s national platform of real estate big data and . . .
→ Read full post: SmartZip’s Predictive Marketing platform achieves 300% annual growth
by Nat Goldhaber on April 2nd, 2013 
Nat Goldhaber
EcoFactor and Sentilla just won the Greentech Media Research’s 2013 Smart Grid Innovation award. These awards, which were unveiled as part of the research firm’s newly released The Networked Grid 150 vendor ecosysystem report, recognize best-in-class products and services in the smart grid market.
Hearty congratulations to the teams at EcoFactor and Sentilla.
EcoFactor ’s energy management services provide utilities . . .
→ Read full post: Congratulations to EcoFactor and Sentilla, winners of GTM Research’s Smart Grid Innovation award
by Ted Driscoll on February 23rd, 2013
Congratulations to Natera—our portfolio company who is the leading innovator in prenatal genetic testing! Yesterday they announced a major deal with Quest Diagnostics (NYSE: DGX), the world’s leading diagnostic information services company. Quest Diagnostics will offer physicians access to Panorama™, the new non-invasive prenatal test developed by Natera. (Read the Quest Press Release)
Panorama uses free-floating fetal DNA in circulating maternal blood to screen for chromosomal abnormalities associated with . . .
→ Read full post: Congratulations: Quest Diagnostics to offer access to Natera’s Panorama, non-invasive prenatal test
by Claremont Creek Alerts on January 5th, 2013 
January 5, 2013 source: GigaOm
GigaOm’s article 13 energy data startups to watch in 2013 includes one of our portfolio companies, EcoFactor. GigaOm said, “Data analytics took the energy sector by storm in 2012, and a bunch of companies launched, raised funding and grew their businesses last year. Here’s 13 energy data startups you should watch in 2013.”
. . .
→ Read full post: Congratulations to EcoFactor who is one of GigaOm’s energy data startups to watch in 2013
by Randy Hawks on December 10th, 2012
December 10, 2012 source: The Economist
It’s the holiday season and this year, 4G smartphones and tablets are the gifts most desired under the Christmas tree. But buying that new iPhone or Android could have its consequences. As mobile-phone technology advances by the minute, holding on to yesterday’s popular cell phone make and model becomes passé, and unfortunately, more likely than not, that “old” cell ends up in the dump. Market-research firm . . .
→ Read full post: Trading Devices for Dollars In The News: ecoATM in The Economist
by Brad Webb on September 17th, 2012 
Bloomberg reporter Ryan Flinn recently wrote an article on Brain Scans Seek Best Drug Match for Depression Patients. The article summarizes some of the technologies that are being used by clinicians to assist in diagnosis and treatment of depression, and focused on technologies provided by two companies. The first company profiled uses a technology that matches EEGs – brain waves – to a database of matched EEG/depression scores, and the second uses a 30-minute . . .
→ Read full post: AssureRx: advanced genomics tools inform patient response to psychotropic therapy
by Claremont Creek Alerts on June 23rd, 2012 
Claremont Creek Ventures portfolio company AssureRx Health continues to receive good press. Below are some excerpts from a recent FoxNews article published June 19, 2012. Read the full article at FoxNews.com
Genetic testing to choose the right antidepressant
By Dr. Keith Ablow.
Psychiatrists often try two or more medications in a patient suffering with major depression before settling on the one that seems to work best for that individual. . . .
→ Read full post: Genetic testing to choose the right antidepressant – AssureRx Health in the news
click to see full-size image
Click here to read the article, and here to visit the Clean Power Finance website.
click to see full-size image
Click here to read the article, and here to visit Alphabet Energy’s website.
|
